NC
ETON icon

NewSquare Capital’s Eton Pharmaceutcials ETON Stock Holding History

NewSquare Capital’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,000
Closed -$4.38K – 467
2023
Q4 		$4.38K Hold
1,000
– – ﹤0.01% 326
2023
Q3 		$4.17K Hold
1,000
– – ﹤0.01% 393
2023
Q2 		$3.49K Hold
1,000
– – ﹤0.01% 461
2023
Q1 		$3.85K Buy
+1,000
New +$3.65K ﹤0.01% 487

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NewSquare Capital's ETON Position: Q1 2024 in Review

NewSquare Capital sold out of Eton Pharmaceutcials (ETON) in Q1 2024, closing a stake of 1,000 shares — an estimated $4.38K sold.

NewSquare Capital first reported a position in ETON in Q1 2023 and held it in 4 quarters. The position peaked at $4.38K in Q4 2023. 44 funds tracked by Wall St. Rank hold ETON as of Q1 2024.

  • NewSquare Capital reported no remaining Eton Pharmaceutcials position as of Q1 2024 after selling out during the quarter.
  • NewSquare Capital sold 1,000 Eton Pharmaceutcials shares in Q1 2024, an estimated $4.38K.
  • NewSquare Capital first reported a position in Eton Pharmaceutcials in Q1 2023 and held it in 4 quarters.
  • NewSquare Capital's Eton Pharmaceutcials position peaked at $4.38K in Q4 2023.
  • 44 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2024.

Based on NewSquare Capital's 13F filing for Q1 2024, filed 8 May 2024.